Association of progression-free survival with patient-reported outcomes and survival: results from a randomised phase 3 trial of panitumumab View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2007-12

AUTHORS

S Siena, M Peeters, E Van Cutsem, Y Humblet, P Conte, E Bajetta, D Comandini, G Bodoky, G Van Hazel, T Salek, M Wolf, G Devercelli, M Woolley, R G Amado

ABSTRACT

In a randomised phase 3 trial, panitumumab significantly improved progression-free survival (PFS) in patients with refractory metastatic colorectal cancer (mCRC). This analysis characterises the association of PFS with CRC symptoms, health-related quality of life (HRQoL), and overall survival (OS). CRC symptoms (NCCN/FACT CRC symptom index, FCSI) and HRQoL (EQ-5D) were assessed for 207 panitumumab patients and 184 best supportive care (BSC) patients who had at least one post-baseline patient-reported outcome (PRO) assessment. Patients alive at week 8 were included in the PRO and OS analyses and categorised by their week 8 progression status as follows: no progressive disease (no PD; best response of at least stable disease) vs progressive disease (PD). Standard imputation methods were used to assign missing values. Significantly more patients were progression free at weeks 8-24 with panitumumab vs BSC. After excluding responders, a significant difference in PFS remained favouring panitumumab (HR=0.63, 95% CI=0.52-0.77; P<0.0001). At week 8, lack of disease progression was associated with significantly and clinically meaningful lower CRC symptomatology for both treatment groups and higher HRQoL for panitumumab patients only. Overall survival favoured no PD patients vs PD patients alive at week 8. Lack of disease progression was associated with better symptom control, HRQoL, and OS. More... »

PAGES

6604053

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/sj.bjc.6604053

DOI

http://dx.doi.org/10.1038/sj.bjc.6604053

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1024434749

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/18040272


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antibodies, Monoclonal", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Colorectal Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Disease Progression", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Administration Schedule", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Resistance, Neoplasm", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Metastasis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Quality of Life", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Receptor, Epidermal Growth Factor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Self-Examination", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Severity of Illness Index", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Survival Analysis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Ospedale Niguarda Ca' Granda", 
          "id": "https://www.grid.ac/institutes/grid.416200.1", 
          "name": [
            "Ospedale Niguarda Ca' Granda, Milan, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Siena", 
        "givenName": "S", 
        "id": "sg:person.01310366350.52", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01310366350.52"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ghent University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.410566.0", 
          "name": [
            "Ghent University Hospital, Ghent, Belgium"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Peeters", 
        "givenName": "M", 
        "id": "sg:person.07540360642.41", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07540360642.41"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Universitaire Ziekenhuizen Leuven", 
          "id": "https://www.grid.ac/institutes/grid.410569.f", 
          "name": [
            "University Hospital Gasthuisberg, Leuven, Belgium"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Van Cutsem", 
        "givenName": "E", 
        "id": "sg:person.01214007230.69", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01214007230.69"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cliniques Universitaires Saint-Luc", 
          "id": "https://www.grid.ac/institutes/grid.48769.34", 
          "name": [
            "St-Luc University Hospital, Brussels, Belgium"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Humblet", 
        "givenName": "Y", 
        "id": "sg:person.01330330130.62", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01330330130.62"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "UO Oncologia Medica \u2013 Centro Oncologico Modenese COM, Modena, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Conte", 
        "givenName": "P", 
        "id": "sg:person.0646473315.72", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0646473315.72"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Istituto per lo Studio a la Cura dei Tumori, Milan, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bajetta", 
        "givenName": "E", 
        "id": "sg:person.01075001254.33", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01075001254.33"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ospedale San Martino", 
          "id": "https://www.grid.ac/institutes/grid.410345.7", 
          "name": [
            "Ospedale San Martino, Genova, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Comandini", 
        "givenName": "D", 
        "id": "sg:person.01015453542.94", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01015453542.94"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Szent L\u00e1szl\u00f3 Hospital, Budapest, Hungary"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bodoky", 
        "givenName": "G", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Clinical Trials Centre, West Perth WA, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Van Hazel", 
        "givenName": "G", 
        "id": "sg:person.0651325573.37", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0651325573.37"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "N\u00e1rodn\u00fd Onkologick\u00fd Ustav", 
          "id": "https://www.grid.ac/institutes/grid.419188.d", 
          "name": [
            "National Cancer Institute, Bratislava, Slovak Republic"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Salek", 
        "givenName": "T", 
        "id": "sg:person.0660720371.23", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0660720371.23"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Amgen (United States)", 
          "id": "https://www.grid.ac/institutes/grid.417886.4", 
          "name": [
            "Amgen Inc., Thousand Oaks, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wolf", 
        "givenName": "M", 
        "id": "sg:person.0610056015.88", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0610056015.88"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Amgen (United States)", 
          "id": "https://www.grid.ac/institutes/grid.417886.4", 
          "name": [
            "Amgen Inc., Thousand Oaks, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Devercelli", 
        "givenName": "G", 
        "id": "sg:person.01360631677.33", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01360631677.33"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Amgen (United States)", 
          "id": "https://www.grid.ac/institutes/grid.417886.4", 
          "name": [
            "Amgen Inc., Thousand Oaks, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Woolley", 
        "givenName": "M", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Amgen (United States)", 
          "id": "https://www.grid.ac/institutes/grid.417886.4", 
          "name": [
            "Amgen Inc., Thousand Oaks, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Amado", 
        "givenName": "R G", 
        "id": "sg:person.0621375352.00", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0621375352.00"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/s1470-2045(05)70102-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000497060"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/1097-0142(20010601)91:11<2033::aid-cncr1229>3.0.co;2-j", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002277356"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijrobp.2003.09.098", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003640255"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(00)02034-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006410174"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2005.03.6723", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007324791"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm200009283431302", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010303757"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdm399", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010952684"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/0008-5472.can-06-0191", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013645791"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa032691", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014051315"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa060655", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025111240"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2004.05.113", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025767346"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jnci/92.3.205", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032301848"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2007.11.5956", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033406421"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa033025", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035161767"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/0008-5472.can-06-4158", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038632088"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2006.08.1620", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043055498"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1081/cnv-120022366", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045309707"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3322/canjclin.55.2.74", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048020321"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11136-004-7713-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050041047", 
          "https://doi.org/10.1007/s11136-004-7713-0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11136-004-7713-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050041047", 
          "https://doi.org/10.1007/s11136-004-7713-0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11136-004-7713-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050041047", 
          "https://doi.org/10.1007/s11136-004-7713-0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2004.10.182", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053488821"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/35052073", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053565592", 
          "https://doi.org/10.1038/35052073"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/35052073", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053565592", 
          "https://doi.org/10.1038/35052073"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/35052073", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053565592", 
          "https://doi.org/10.1038/35052073"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jnci/85.5.365", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1059818446"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/0269216306072555", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1063799823"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/0269216306072555", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1063799823"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2003.11.126", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064203971"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074271661", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2000.18.16.2938", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1074684744"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1998.16.1.139", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1083201628"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2007-12", 
    "datePublishedReg": "2007-12-01", 
    "description": "In a randomised phase 3 trial, panitumumab significantly improved progression-free survival (PFS) in patients with refractory metastatic colorectal cancer (mCRC). This analysis characterises the association of PFS with CRC symptoms, health-related quality of life (HRQoL), and overall survival (OS). CRC symptoms (NCCN/FACT CRC symptom index, FCSI) and HRQoL (EQ-5D) were assessed for 207 panitumumab patients and 184 best supportive care (BSC) patients who had at least one post-baseline patient-reported outcome (PRO) assessment. Patients alive at week 8 were included in the PRO and OS analyses and categorised by their week 8 progression status as follows: no progressive disease (no PD; best response of at least stable disease) vs progressive disease (PD). Standard imputation methods were used to assign missing values. Significantly more patients were progression free at weeks 8-24 with panitumumab vs BSC. After excluding responders, a significant difference in PFS remained favouring panitumumab (HR=0.63, 95% CI=0.52-0.77; P<0.0001). At week 8, lack of disease progression was associated with significantly and clinically meaningful lower CRC symptomatology for both treatment groups and higher HRQoL for panitumumab patients only. Overall survival favoured no PD patients vs PD patients alive at week 8. Lack of disease progression was associated with better symptom control, HRQoL, and OS.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1038/sj.bjc.6604053", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1017082", 
        "issn": [
          "0007-0920", 
          "1532-1827"
        ], 
        "name": "British Journal of Cancer", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "11", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "97"
      }
    ], 
    "name": "Association of progression-free survival with patient-reported outcomes and survival: results from a randomised phase 3 trial of panitumumab", 
    "pagination": "6604053", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "7468ad4c22d2b77fec1b3d414b2ee5a141c8c85763a97ccc73ce8ea2ec45a087"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "18040272"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "0370635"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/sj.bjc.6604053"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1024434749"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/sj.bjc.6604053", 
      "https://app.dimensions.ai/details/publication/pub.1024434749"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T17:19", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8672_00000424.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://www.nature.com/articles/6604053"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6604053'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6604053'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6604053'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/sj.bjc.6604053'


 

This table displays all metadata directly associated to this object as RDF triples.

318 TRIPLES      21 PREDICATES      69 URIs      34 LITERALS      22 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/sj.bjc.6604053 schema:about N16c9a3faa6cf41358ee2217becb55c4f
2 N191e9207b04c489a9daa625b738b7144
3 N1d8ad128620b424393e83ae68aa616f4
4 N36edefb858da45e4b3e10672b750d247
5 N48e6250dbbcb403f8e7d2066fb6b7259
6 N5393947e8bf648b5a34a1c822304da4f
7 N53e5b5e725804bcb9ef74a328d9ac275
8 N65ce6f5ac7ca4774847f587a5c30ab9e
9 N88c09cdf94eb499a858434fdd92c521c
10 N8d1e43bc9cf6423c97d8b2f78e9dc945
11 Na1b55b9eb772432090d4eb4f5710700a
12 Na7ee8e4843a84bcfa9cbeb447daffc39
13 Ncaae2c6e22a643d39d1415affa7e60aa
14 anzsrc-for:11
15 anzsrc-for:1112
16 schema:author Nd8fdc493dfc2412f8ce5a2f84ea8ef3e
17 schema:citation sg:pub.10.1007/s11136-004-7713-0
18 sg:pub.10.1038/35052073
19 https://app.dimensions.ai/details/publication/pub.1074271661
20 https://doi.org/10.1002/1097-0142(20010601)91:11<2033::aid-cncr1229>3.0.co;2-j
21 https://doi.org/10.1016/j.ijrobp.2003.09.098
22 https://doi.org/10.1016/s0140-6736(00)02034-1
23 https://doi.org/10.1016/s1470-2045(05)70102-9
24 https://doi.org/10.1056/nejm200009283431302
25 https://doi.org/10.1056/nejmoa032691
26 https://doi.org/10.1056/nejmoa033025
27 https://doi.org/10.1056/nejmoa060655
28 https://doi.org/10.1081/cnv-120022366
29 https://doi.org/10.1093/annonc/mdm399
30 https://doi.org/10.1093/jnci/85.5.365
31 https://doi.org/10.1093/jnci/92.3.205
32 https://doi.org/10.1158/0008-5472.can-06-0191
33 https://doi.org/10.1158/0008-5472.can-06-4158
34 https://doi.org/10.1177/0269216306072555
35 https://doi.org/10.1200/jco.1998.16.1.139
36 https://doi.org/10.1200/jco.2000.18.16.2938
37 https://doi.org/10.1200/jco.2003.11.126
38 https://doi.org/10.1200/jco.2004.05.113
39 https://doi.org/10.1200/jco.2004.10.182
40 https://doi.org/10.1200/jco.2005.03.6723
41 https://doi.org/10.1200/jco.2006.08.1620
42 https://doi.org/10.1200/jco.2007.11.5956
43 https://doi.org/10.3322/canjclin.55.2.74
44 schema:datePublished 2007-12
45 schema:datePublishedReg 2007-12-01
46 schema:description In a randomised phase 3 trial, panitumumab significantly improved progression-free survival (PFS) in patients with refractory metastatic colorectal cancer (mCRC). This analysis characterises the association of PFS with CRC symptoms, health-related quality of life (HRQoL), and overall survival (OS). CRC symptoms (NCCN/FACT CRC symptom index, FCSI) and HRQoL (EQ-5D) were assessed for 207 panitumumab patients and 184 best supportive care (BSC) patients who had at least one post-baseline patient-reported outcome (PRO) assessment. Patients alive at week 8 were included in the PRO and OS analyses and categorised by their week 8 progression status as follows: no progressive disease (no PD; best response of at least stable disease) vs progressive disease (PD). Standard imputation methods were used to assign missing values. Significantly more patients were progression free at weeks 8-24 with panitumumab vs BSC. After excluding responders, a significant difference in PFS remained favouring panitumumab (HR=0.63, 95% CI=0.52-0.77; P<0.0001). At week 8, lack of disease progression was associated with significantly and clinically meaningful lower CRC symptomatology for both treatment groups and higher HRQoL for panitumumab patients only. Overall survival favoured no PD patients vs PD patients alive at week 8. Lack of disease progression was associated with better symptom control, HRQoL, and OS.
47 schema:genre research_article
48 schema:inLanguage en
49 schema:isAccessibleForFree true
50 schema:isPartOf N7c6aaea23b854dca8bdcf9ce23b00b8f
51 N9e4ebb9393c64aba8f079726161720d8
52 sg:journal.1017082
53 schema:name Association of progression-free survival with patient-reported outcomes and survival: results from a randomised phase 3 trial of panitumumab
54 schema:pagination 6604053
55 schema:productId N31905f05636c47fda1665eddbe9e34df
56 N53897e84b56f4329abaf1590b31a12de
57 Nbbaeb8fbdf16443e91d8c4416ab16fe2
58 Nc1f383adc4f54118a2c8f1cc6e1ec7ae
59 Nfcdfbe0eaea24987801b93de50917be6
60 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024434749
61 https://doi.org/10.1038/sj.bjc.6604053
62 schema:sdDatePublished 2019-04-10T17:19
63 schema:sdLicense https://scigraph.springernature.com/explorer/license/
64 schema:sdPublisher N6db276b6f272406f9409ddb30e18a410
65 schema:url http://www.nature.com/articles/6604053
66 sgo:license sg:explorer/license/
67 sgo:sdDataset articles
68 rdf:type schema:ScholarlyArticle
69 N110fc0f9dbce486d86220df74ed00282 rdf:first sg:person.01360631677.33
70 rdf:rest N98bfe4a2ede84ae08ef3d81760463e15
71 N16c9a3faa6cf41358ee2217becb55c4f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
72 schema:name Colorectal Neoplasms
73 rdf:type schema:DefinedTerm
74 N191e9207b04c489a9daa625b738b7144 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
75 schema:name Humans
76 rdf:type schema:DefinedTerm
77 N1d8ad128620b424393e83ae68aa616f4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
78 schema:name Treatment Outcome
79 rdf:type schema:DefinedTerm
80 N1ecc701d532844b0b8b84a980ed1e230 rdf:first sg:person.07540360642.41
81 rdf:rest N61d4d25ff76041a285bfacf157095275
82 N2a6358bd5c9a4d339c6b0dcd99b995cf schema:name Szent László Hospital, Budapest, Hungary
83 rdf:type schema:Organization
84 N31905f05636c47fda1665eddbe9e34df schema:name nlm_unique_id
85 schema:value 0370635
86 rdf:type schema:PropertyValue
87 N36edefb858da45e4b3e10672b750d247 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
88 schema:name Survival Analysis
89 rdf:type schema:DefinedTerm
90 N48e6250dbbcb403f8e7d2066fb6b7259 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
91 schema:name Quality of Life
92 rdf:type schema:DefinedTerm
93 N48f7ae388d5c4c68ad25cf3a3ce8e324 rdf:first sg:person.01330330130.62
94 rdf:rest N5ffd2aa2f3834423a309c6aa2a0ff7c1
95 N53897e84b56f4329abaf1590b31a12de schema:name dimensions_id
96 schema:value pub.1024434749
97 rdf:type schema:PropertyValue
98 N5393947e8bf648b5a34a1c822304da4f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
99 schema:name Drug Administration Schedule
100 rdf:type schema:DefinedTerm
101 N53e5b5e725804bcb9ef74a328d9ac275 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
102 schema:name Self-Examination
103 rdf:type schema:DefinedTerm
104 N57a5f67fe7774486b98343947708cd90 rdf:first sg:person.01015453542.94
105 rdf:rest N5acb39a0cda94b1686ffa5474a1cef9a
106 N5acb39a0cda94b1686ffa5474a1cef9a rdf:first N9f5eb56a53534e3bba54fee8309477c7
107 rdf:rest Nff897fdd323b47a19c46522e97e4a470
108 N5ffd2aa2f3834423a309c6aa2a0ff7c1 rdf:first sg:person.0646473315.72
109 rdf:rest N749f96a71c714a17a4bc529aa423206f
110 N61d4d25ff76041a285bfacf157095275 rdf:first sg:person.01214007230.69
111 rdf:rest N48f7ae388d5c4c68ad25cf3a3ce8e324
112 N65ce6f5ac7ca4774847f587a5c30ab9e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Receptor, Epidermal Growth Factor
114 rdf:type schema:DefinedTerm
115 N6db276b6f272406f9409ddb30e18a410 schema:name Springer Nature - SN SciGraph project
116 rdf:type schema:Organization
117 N71dc9d99cbce46e7a69f0ff3117a745d schema:affiliation https://www.grid.ac/institutes/grid.417886.4
118 schema:familyName Woolley
119 schema:givenName M
120 rdf:type schema:Person
121 N749f96a71c714a17a4bc529aa423206f rdf:first sg:person.01075001254.33
122 rdf:rest N57a5f67fe7774486b98343947708cd90
123 N7c6aaea23b854dca8bdcf9ce23b00b8f schema:volumeNumber 97
124 rdf:type schema:PublicationVolume
125 N88c09cdf94eb499a858434fdd92c521c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Severity of Illness Index
127 rdf:type schema:DefinedTerm
128 N8d1e43bc9cf6423c97d8b2f78e9dc945 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Antibodies, Monoclonal
130 rdf:type schema:DefinedTerm
131 N8e0914dddae54c31b855efb6ffdd3254 rdf:first sg:person.0621375352.00
132 rdf:rest rdf:nil
133 N98bfe4a2ede84ae08ef3d81760463e15 rdf:first N71dc9d99cbce46e7a69f0ff3117a745d
134 rdf:rest N8e0914dddae54c31b855efb6ffdd3254
135 N9e4ebb9393c64aba8f079726161720d8 schema:issueNumber 11
136 rdf:type schema:PublicationIssue
137 N9f5eb56a53534e3bba54fee8309477c7 schema:affiliation N2a6358bd5c9a4d339c6b0dcd99b995cf
138 schema:familyName Bodoky
139 schema:givenName G
140 rdf:type schema:Person
141 Na1b55b9eb772432090d4eb4f5710700a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Drug Resistance, Neoplasm
143 rdf:type schema:DefinedTerm
144 Na7ee8e4843a84bcfa9cbeb447daffc39 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Disease Progression
146 rdf:type schema:DefinedTerm
147 Nbbaeb8fbdf16443e91d8c4416ab16fe2 schema:name doi
148 schema:value 10.1038/sj.bjc.6604053
149 rdf:type schema:PropertyValue
150 Nc1f383adc4f54118a2c8f1cc6e1ec7ae schema:name pubmed_id
151 schema:value 18040272
152 rdf:type schema:PropertyValue
153 Nc590baa0a43042b498d152d76a21bf4a schema:name UO Oncologia Medica – Centro Oncologico Modenese COM, Modena, Italy
154 rdf:type schema:Organization
155 Ncaae2c6e22a643d39d1415affa7e60aa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Neoplasm Metastasis
157 rdf:type schema:DefinedTerm
158 Nd8fdc493dfc2412f8ce5a2f84ea8ef3e rdf:first sg:person.01310366350.52
159 rdf:rest N1ecc701d532844b0b8b84a980ed1e230
160 Ne7093fd23c0643d1bdb3392db5616883 rdf:first sg:person.0610056015.88
161 rdf:rest N110fc0f9dbce486d86220df74ed00282
162 Ne98a4bf537ee4d79b568f07692f4e402 schema:name Istituto per lo Studio a la Cura dei Tumori, Milan, Italy
163 rdf:type schema:Organization
164 Nebd326183ee64566976907fe569888c3 schema:name Clinical Trials Centre, West Perth WA, Australia
165 rdf:type schema:Organization
166 Nfb75d8ee730e4318a6286c460d9b1d5e rdf:first sg:person.0660720371.23
167 rdf:rest Ne7093fd23c0643d1bdb3392db5616883
168 Nfcdfbe0eaea24987801b93de50917be6 schema:name readcube_id
169 schema:value 7468ad4c22d2b77fec1b3d414b2ee5a141c8c85763a97ccc73ce8ea2ec45a087
170 rdf:type schema:PropertyValue
171 Nff897fdd323b47a19c46522e97e4a470 rdf:first sg:person.0651325573.37
172 rdf:rest Nfb75d8ee730e4318a6286c460d9b1d5e
173 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
174 schema:name Medical and Health Sciences
175 rdf:type schema:DefinedTerm
176 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
177 schema:name Oncology and Carcinogenesis
178 rdf:type schema:DefinedTerm
179 sg:journal.1017082 schema:issn 0007-0920
180 1532-1827
181 schema:name British Journal of Cancer
182 rdf:type schema:Periodical
183 sg:person.01015453542.94 schema:affiliation https://www.grid.ac/institutes/grid.410345.7
184 schema:familyName Comandini
185 schema:givenName D
186 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01015453542.94
187 rdf:type schema:Person
188 sg:person.01075001254.33 schema:affiliation Ne98a4bf537ee4d79b568f07692f4e402
189 schema:familyName Bajetta
190 schema:givenName E
191 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01075001254.33
192 rdf:type schema:Person
193 sg:person.01214007230.69 schema:affiliation https://www.grid.ac/institutes/grid.410569.f
194 schema:familyName Van Cutsem
195 schema:givenName E
196 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01214007230.69
197 rdf:type schema:Person
198 sg:person.01310366350.52 schema:affiliation https://www.grid.ac/institutes/grid.416200.1
199 schema:familyName Siena
200 schema:givenName S
201 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01310366350.52
202 rdf:type schema:Person
203 sg:person.01330330130.62 schema:affiliation https://www.grid.ac/institutes/grid.48769.34
204 schema:familyName Humblet
205 schema:givenName Y
206 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01330330130.62
207 rdf:type schema:Person
208 sg:person.01360631677.33 schema:affiliation https://www.grid.ac/institutes/grid.417886.4
209 schema:familyName Devercelli
210 schema:givenName G
211 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01360631677.33
212 rdf:type schema:Person
213 sg:person.0610056015.88 schema:affiliation https://www.grid.ac/institutes/grid.417886.4
214 schema:familyName Wolf
215 schema:givenName M
216 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0610056015.88
217 rdf:type schema:Person
218 sg:person.0621375352.00 schema:affiliation https://www.grid.ac/institutes/grid.417886.4
219 schema:familyName Amado
220 schema:givenName R G
221 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0621375352.00
222 rdf:type schema:Person
223 sg:person.0646473315.72 schema:affiliation Nc590baa0a43042b498d152d76a21bf4a
224 schema:familyName Conte
225 schema:givenName P
226 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0646473315.72
227 rdf:type schema:Person
228 sg:person.0651325573.37 schema:affiliation Nebd326183ee64566976907fe569888c3
229 schema:familyName Van Hazel
230 schema:givenName G
231 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0651325573.37
232 rdf:type schema:Person
233 sg:person.0660720371.23 schema:affiliation https://www.grid.ac/institutes/grid.419188.d
234 schema:familyName Salek
235 schema:givenName T
236 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0660720371.23
237 rdf:type schema:Person
238 sg:person.07540360642.41 schema:affiliation https://www.grid.ac/institutes/grid.410566.0
239 schema:familyName Peeters
240 schema:givenName M
241 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07540360642.41
242 rdf:type schema:Person
243 sg:pub.10.1007/s11136-004-7713-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050041047
244 https://doi.org/10.1007/s11136-004-7713-0
245 rdf:type schema:CreativeWork
246 sg:pub.10.1038/35052073 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053565592
247 https://doi.org/10.1038/35052073
248 rdf:type schema:CreativeWork
249 https://app.dimensions.ai/details/publication/pub.1074271661 schema:CreativeWork
250 https://doi.org/10.1002/1097-0142(20010601)91:11<2033::aid-cncr1229>3.0.co;2-j schema:sameAs https://app.dimensions.ai/details/publication/pub.1002277356
251 rdf:type schema:CreativeWork
252 https://doi.org/10.1016/j.ijrobp.2003.09.098 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003640255
253 rdf:type schema:CreativeWork
254 https://doi.org/10.1016/s0140-6736(00)02034-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006410174
255 rdf:type schema:CreativeWork
256 https://doi.org/10.1016/s1470-2045(05)70102-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000497060
257 rdf:type schema:CreativeWork
258 https://doi.org/10.1056/nejm200009283431302 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010303757
259 rdf:type schema:CreativeWork
260 https://doi.org/10.1056/nejmoa032691 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014051315
261 rdf:type schema:CreativeWork
262 https://doi.org/10.1056/nejmoa033025 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035161767
263 rdf:type schema:CreativeWork
264 https://doi.org/10.1056/nejmoa060655 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025111240
265 rdf:type schema:CreativeWork
266 https://doi.org/10.1081/cnv-120022366 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045309707
267 rdf:type schema:CreativeWork
268 https://doi.org/10.1093/annonc/mdm399 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010952684
269 rdf:type schema:CreativeWork
270 https://doi.org/10.1093/jnci/85.5.365 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059818446
271 rdf:type schema:CreativeWork
272 https://doi.org/10.1093/jnci/92.3.205 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032301848
273 rdf:type schema:CreativeWork
274 https://doi.org/10.1158/0008-5472.can-06-0191 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013645791
275 rdf:type schema:CreativeWork
276 https://doi.org/10.1158/0008-5472.can-06-4158 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038632088
277 rdf:type schema:CreativeWork
278 https://doi.org/10.1177/0269216306072555 schema:sameAs https://app.dimensions.ai/details/publication/pub.1063799823
279 rdf:type schema:CreativeWork
280 https://doi.org/10.1200/jco.1998.16.1.139 schema:sameAs https://app.dimensions.ai/details/publication/pub.1083201628
281 rdf:type schema:CreativeWork
282 https://doi.org/10.1200/jco.2000.18.16.2938 schema:sameAs https://app.dimensions.ai/details/publication/pub.1074684744
283 rdf:type schema:CreativeWork
284 https://doi.org/10.1200/jco.2003.11.126 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064203971
285 rdf:type schema:CreativeWork
286 https://doi.org/10.1200/jco.2004.05.113 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025767346
287 rdf:type schema:CreativeWork
288 https://doi.org/10.1200/jco.2004.10.182 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053488821
289 rdf:type schema:CreativeWork
290 https://doi.org/10.1200/jco.2005.03.6723 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007324791
291 rdf:type schema:CreativeWork
292 https://doi.org/10.1200/jco.2006.08.1620 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043055498
293 rdf:type schema:CreativeWork
294 https://doi.org/10.1200/jco.2007.11.5956 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033406421
295 rdf:type schema:CreativeWork
296 https://doi.org/10.3322/canjclin.55.2.74 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048020321
297 rdf:type schema:CreativeWork
298 https://www.grid.ac/institutes/grid.410345.7 schema:alternateName Ospedale San Martino
299 schema:name Ospedale San Martino, Genova, Italy
300 rdf:type schema:Organization
301 https://www.grid.ac/institutes/grid.410566.0 schema:alternateName Ghent University Hospital
302 schema:name Ghent University Hospital, Ghent, Belgium
303 rdf:type schema:Organization
304 https://www.grid.ac/institutes/grid.410569.f schema:alternateName Universitaire Ziekenhuizen Leuven
305 schema:name University Hospital Gasthuisberg, Leuven, Belgium
306 rdf:type schema:Organization
307 https://www.grid.ac/institutes/grid.416200.1 schema:alternateName Ospedale Niguarda Ca' Granda
308 schema:name Ospedale Niguarda Ca' Granda, Milan, Italy
309 rdf:type schema:Organization
310 https://www.grid.ac/institutes/grid.417886.4 schema:alternateName Amgen (United States)
311 schema:name Amgen Inc., Thousand Oaks, CA, USA
312 rdf:type schema:Organization
313 https://www.grid.ac/institutes/grid.419188.d schema:alternateName Národný Onkologický Ustav
314 schema:name National Cancer Institute, Bratislava, Slovak Republic
315 rdf:type schema:Organization
316 https://www.grid.ac/institutes/grid.48769.34 schema:alternateName Cliniques Universitaires Saint-Luc
317 schema:name St-Luc University Hospital, Brussels, Belgium
318 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...